Anti-F3/Factor III/Tissue Factor/CD142 Antibody represents a highly specialized monoclonal antibody specifically engineered to target the human Tissue Factor (TF/CD142) with exceptional binding affinity. It effectively facilitates the measurable targeting of TF-expressing malignant cells across various preclinical experimental models to evaluate the delivery of cytotoxic payloads or the disruption of TF-mediated oncogenic signaling during strictly monitored laboratory observation periods and functional cell viability assays without compromising systemic coagulation homeostasis.